We came across a bullish thesis on Enovis Corporation on Value investing subreddit by TheBestOfAllTylers. In this article, we will summarize the bulls’ thesis on ENOV. Enovis Corporation's share was trading at $24.66 as of January 13th. ENOV’s forward P/E was 6.85 according to Yahoo Finance.
[caption id="attachment_575610" align="aligncenter" width="750"]Enovis operates as a specialized challenger platform in musculoskeletal healthcare, combining a high-margin, surgeon-driven implant franchise with a faster-turning but lower-margin...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.